Are Robust Financials Driving The Recent Rally In Arvida Group Limited's (NZSE:ARV) Stock?

  • In Business
  • 2022-08-12 22:47:43Z
  • By Simply Wall St.

Most readers would already be aware that Arvida Group's (NZSE:ARV) stock increased significantly by 12% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. In this article, we decided to focus on Arvida Group's ROE.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

View our latest analysis for Arvida Group

How Is ROE Calculated?

The formula for return on equity is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Arvida Group is:

15% = NZ$199m ÷ NZ$1.3b (Based on the trailing twelve months to March 2022).

The 'return' is the income the business earned over the last year. That means that for every NZ$1 worth of shareholders' equity, the company generated NZ$0.15 in profit.

Why Is ROE Important For Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

A Side By Side comparison of Arvida Group's Earnings Growth And 15% ROE

To start with, Arvida Group's ROE looks acceptable. Even when compared to the industry average of 15% the company's ROE looks quite decent. Consequently, this likely laid the ground for the impressive net income growth of 28% seen over the past five years by Arvida Group. We believe that there might also be other aspects that are positively influencing the company's earnings growth. Such as - high earnings retention or an efficient management in place.

We then compared Arvida Group's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 9.6% in the same period.

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. Has the market priced in the future outlook for ARV? You can find out in our latest intrinsic value infographic research report.

Is Arvida Group Efficiently Re-investing Its Profits?

The three-year median payout ratio for Arvida Group is 34%, which is moderately low. The company is retaining the remaining 66%. This suggests that its dividend is well covered, and given the high growth we discussed above, it looks like Arvida Group is reinvesting its earnings efficiently.

Additionally, Arvida Group has paid dividends over a period of seven years which means that the company is pretty serious about sharing its profits with shareholders. Looking at the current analyst consensus data, we can see that the company's future payout ratio is expected to rise to 45% over the next three years. Therefore, the expected rise in the payout ratio explains why the company's ROE is expected to decline to 8.0% over the same period.


On the whole, we feel that Arvida Group's performance has been quite good. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. With that said, on studying the latest analyst forecasts, we found that while the company has seen growth in its past earnings, analysts expect its future earnings to shrink. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here


More Related News

Are TE Connectivity Ltd.
Are TE Connectivity Ltd.'s (NYSE:TEL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

It is hard to get excited after looking at TE Connectivity's (NYSE:TEL) recent performance, when its stock has declined...

Magic Software Enterprises Ltd. (NASDAQ:MGIC) Stock
Magic Software Enterprises Ltd. (NASDAQ:MGIC) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Magic Software Enterprises (NASDAQ:MGIC) has had a rough month with its share price down 13%. However, the company's...

Should You Be Adding Harte Hanks (NASDAQ:HHS) To Your Watchlist Today?
Should You Be Adding Harte Hanks (NASDAQ:HHS) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Will Weakness in Ironwood Pharmaceuticals, Inc.
Will Weakness in Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Stock Prove Temporary Given Strong Fundamentals?

Ironwood Pharmaceuticals (NASDAQ:IRWD) has had a rough month with its share price down 11%. However, stock prices are...

What Leidos Holdings, Inc.
What Leidos Holdings, Inc.'s (NYSE:LDOS) ROE Can Tell Us

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


  • ICE at Gaylord Palms
    (2022-08-13 12:59:59Z)

    I would like to say that this blog really convinced me to do it! Thanks, very good post.


Top News: Business